Tristel (LON:TSTL) Sets New 1-Year High at $510.00

Tristel plc (LON:TSTL) hit a new 52-week high on Thursday . The stock traded as high as GBX 510 ($6.56) and last traded at GBX 498.23 ($6.41), with a volume of 128069 shares traded. The stock had previously closed at GBX 490 ($6.30).

Tristel Trading Up 1.7 %

The firm has a market cap of £236.86 million, a price-to-earnings ratio of 3,832.50 and a beta of 0.26. The company has a quick ratio of 3.83, a current ratio of 4.92 and a debt-to-equity ratio of 19.12. The business has a 50 day moving average price of GBX 449.89 and a 200-day moving average price of GBX 454.50.

Insiders Place Their Bets

In other news, insider Elizabeth Dixon sold 29,000 shares of Tristel stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of GBX 440 ($5.66), for a total transaction of £127,600 ($164,136.87). 5.29% of the stock is owned by company insiders.

Tristel Company Profile

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.